Clinical Program Leader (CPL) in Cambridge

Location: Cambridge, MA. Hybrid. May consider DWA, but candidates local to onsite preferred.

Experience will determine which level (Senior CPL or CPL) is appropriate after interview process based on skills and experience.

CPL: Provides strategic medical guidance and leads the development of experimental oncology agents in the TCO portfolio, beginning with PE / DC (Portfolio Entry / Drug Candidate) of preclinical development and continuing through TDP (Transition Decision Point).

Major Accountabilities

• Provides strategic medical and scientific leadership and expertise to all line functions on the project team for the development of new oncology agents (e.g., small molecules, biologics, radioligand therapies) that are in preclinical development, typically beginning at the PE / DC.
• Creates clinical development strategies for new oncology agents within the PE/ DC to TDP timeframe, combining the CPL’s medical knowledge with the expertise of colleagues in various disciplines (e.g., Clinical Pharmacology, Biostatistics) to optimise the clinical development strategy.
• Delivers solutions within functions, across functions, and on global projects, developing an independent approach to TCO strategy.
• Develops the Integrated Development Plan Approval (IDPA) in alignment with CPL Disease Area Leads (DALs), Development (DEV), Strategy & Growth (S&G), and Commercial teams.
• Leads Biomedical Research Early Program Teams (BPTs) to enable the start of clinical development and continuing through clinical trials needed to support TDP.
• Integrates preclinical information (pharmacology, toxicology, and pharmacokinetics) and interprets implications for clinical development, as articulated in the Investigator’s Brochure and First-in-Human protocol.
• Collaborates with clinical scientists to develop clinical protocols for TCO compounds and develops the instruments needed to implement, interpret and report them (e.g., case report forms, report and analysis plans, clinical study reports).
• Applies own medical knowledge to guide the safe, ethical and efficient conduct of the trials under own responsibility, knowledgeable in Good Clinical Practice guidelines and Novartis Standard Operating Procedures.
• Liaises with outside experts, investigators, and regulatory authorities in oncology, representing own projects to those groups and authorities.
• Writes and reviews abstracts/manuscripts for presentation/publications at internal/external meetings.
• Participates in task forces to support continuous improvement and other management objectives, with operational responsibility for quality and compliance.
• May provide informal mentorship to less experienced CPLs.

Qualifications:

• Education: MD or DO degree; Board-certification in an oncology specialty and PhD-level science are preferred.
• Languages: Fluent English – Oral and written.
• Experience/Professional requirement: At least 2 years of pharmaceutical/biotech industry experience in oncology clinical trials plus equivalent duration experience from an academic medical centre. If limited or no Pharmaceutical industry experience, then comparable senior academic experience in translational oncology and clinical research.
• Recognised as an expert in your field by external medical experts, with a substantial record of publication and international recognition.
• Excellent interpretation of oncology preclinical data (molecular biology, pharmacology, pharmacokinetics, and toxicology).
• Strong knowledge of the application of PK/PD and biostatistics to clinical development and clinical trials.
• Proven ability to analyse and interpret efficacy and safety data relating to oncology.
• Knowledge of GCP and worldwide regulatory requirements for clinical trials and oncology.
• Excellent medical/scientific writing skills.
• Successful track record of strategic thinking.
• Proven ability to develop and inspire project/line/matrix multidisciplinary teams in a global environment.
• Excellent personal ethical integrity and a commitment to improving outcomes for patients with malignancies.
• Excellent written and oral English communication/presentation skills.
• Strong office IT skills.

Compensation and Benefits Summary:

The salary for this position is expected to range between $248,500.00 - 461,500.00 USD Annual per year. The final salary offered is determined based on factors like relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors.

Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards. US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.

EEO Statement: The Novartis Group of Companies are Equal Opportunity Employers. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, colour, religion, sex, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status.

Accessibility and reasonable accommodations: The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or to perform the essential functions of a position, please send an e-mail to us.reasonableaccommodations@novartis.com or call +1(877)395-2339 and let us know the nature of your request and your contact information. Please include the job requisition number in your message.